Radius Health News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

11.08.22	Menarini Group's Elacestrant Granted Priority Review by the U.S. FDA for Patients with ER+/HER2- Advanced or Metastatic Breast Cancer (PR Newswire)
11.07.22	INVESTIGATION NOTICE: Halper Sadeh LLP Investigates DRE, RDUS, FSTX, RADA, USAK (PR Newswire)
06.07.22	INVESTIGATION NOTICE: Halper Sadeh LLP Investigates VMW, CMAX, RDUS, FSTX (PR Newswire)
27.06.22	INVESTIGATION NOTICE: Halper Sadeh LLP Investigates RDUS, FSTX, ZEN, USAK (PR Newswire)
23.06.22	Menarini Submits NDA To FDA For Elacestrant (RTTNews)
23.06.22	Menarini Group and Radius Health Submit New Drug Application to the U.S. FDA for Elacestrant (PR Newswire)
06.06.22	Menarini Group and Radius Health, Inc. present a subgroup analysis from the elacestrant pivotal phase 3 EMERALD clinical trial at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting (PR Newswire)
20.05.22	Italy's Menarini, Radius Health Report Positive Data From Elacestrant Phase 3 EMERALD Clinical Trial (RTTNews)
20.05.22	Menarini Group and Radius Health, Inc. announce publication of elacestrant pivotal Phase 3 EMERALD clinical trial data in the Journal of Clinical Oncology (PR Newswire)
09.12.21	AZN's Antibody Authorized For COVID-19, RDUS Shrinks, ZYME On Watch, FDA Panel Snubs RETA (RTTNews)
18.10.21	Radius Reports Positive Phase 3 Results For TYMLOS Subcutaneous Injection In Males With Osteoporosis (RTTNews)
23.03.21	AZN's COVID-19 Jab Shows 79% Efficacy, ZEAL Wins FDA Approval, AdComm To Review Osteoarthritis Drug (RTTNews)
05.01.21	Endo Says Paladin Labs To Commercialize Abaloparatide In Canada Under Licensing Deal - Quick Facts (RTTNews)
18.03.18	Radius Health Presents Positive Data From ACTIVExtend BMD Responder Analysis (RTTNews)
17.08.17	Stock Performance Review on Biotech Industry -- Radius Health, Abeona Therapeutics, Catalyst Biosciences, and Cerecor (PR Newswire)
18.07.17	Gainers & Losers Of July 17: ACRX, QDEL, AKCA, SGMO, SUPN... (RTTNews)
28.06.17	Technical Snapshots for These Biotech Stocks -- Merrimack Pharma, MannKind, GlycoMimetics, and Radius Health (PR Newswire)
06.06.17	Gainers & Losers Of June 5: LOXO, CLSN, RDUS, GLYC, JUNO... (RTTNews)
23.05.17	Increasing Flurry of FDA Orphan Drug Development Activity Fueling Uptick of Enthusiasm for Few Pharma Stocks (PR Newswire)
23.05.17	Increasing Flurry of FDA Orphan Drug Development Activity Fueling Uptick of Enthusiasm for Few Pharma Stocks (PR Newswire)
11.05.17	Research Reports Coverage on Healthcare Stocks -- Radius Health, bluebird bio, Universal Health Services, and LifePoint Health (PR Newswire)
02.05.17	Gainers & Losers Of May 1: VTGN, VSTM, TOCA, NTRP, AEZS... (RTTNews)
30.04.17	Monday Is D-Day For AEZS, Watch Out For MRUS, FDA Nod For RDUS & Takeda (RTTNews)
22.03.17	Research Reports Initiation on Biotech Stocks -- Radius Health, Acorda, PhaseRx, and Athersys (PR Newswire)
27.02.17	Biotech Stocks Facing FDA Decision In March (RTTNews)
27.01.17	Research Reports Coverage on Biotech Stocks -- Idera Pharma, Ocular Therapeutix, Radius Health, and Grifols (PR Newswire)
15.12.16	How These Biotech Stocks are Faring? -- Agenus, Kite Pharma, Ocular Therapeutix, and Radius Health (PR Newswire)
22.12.14	Radius Health Study Meets Main Goal In Incident Vertebral Fracture Patients (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Swisscom	530.00	2.91 %	K V
Holcim	95.70	1.59 %	K V
UBS Group	30.50	1.13 %	K V
ABB	50.06	0.93 %	K V
Roche Hldg G	290.10	0.83 %	K V
Sika	231.90	-0.60 %	K V
Givaudan	3’884.00	-0.61 %	K V
Lonza Grp	608.20	-0.78 %	K V
Geberit	510.00	-1.35 %	K V
Part Grp Hldg	1’394.50	-1.66 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Radius Health Inc

Aktien Top/Flop

Meistgelesene Nachrichten